ATHXQ — Athersys Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.77m
- $5.33m
Brief: Athersys Inc Announces Restructuring, Management Changes To Focus On Existing Clinical Programs
U.S. STOCKS ON THE MOVE-Immix Biopharma, Apple Inc, Chimerix Inc
U.S. STOCKS ON THE MOVE-Wix.com Ltd, VF Corp, Evofem Biosciences
Athersys crashes after cell therapy fails stroke study
Brief: Athersys Files For Common Stock Offering Of Up To $100 Million - SEC Filing
Brief: Athersys Reports First Quarter 2022 Results
Brief: Athersys Files For Mixed Shelf Of Up To $250 Million
Athersys Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Athersys Reports That Its Partner, Healios K.K., Provides Updates On Multistem Clinical Programs In Japan
Brief: Athersys Says Received Notice From Nasdaq That Co Is Not In Compliance With Minimum Closing Bid Price Requirement
Athersys Inc reports results for the quarter ended in December - Earnings Summary
Brief: Athersys Reports Q4 Revenue Of $700,000
Athersys Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, To Chief Executive Officer
U.S. STOCKS ON THE MOVE-Didi, MEI Pharma, TG Therapeutics, Cumberland Pharma
U.S. STOCKS ON THE MOVE-Facebook, Tesla, Regeneron Pharma, ImmunoGen
Athersys jumps as respiratory disease treatment shows promise in early trials
Brief: Athersys Publishes Report Of Clinical Trial For Acute Respiratory Distress Syndrome Treatment
Athersys Inc reports results for the quarter ended in September - Earnings Summary